Table 2 Mean scores for negative moods and distress, and percentage of men with scores of clinical significancea

From: Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result

 

PSA test (time-point 1)

Biopsy (time-point 2)

Post-negative result (time-point 3)

12-week follow-up (time-point 4)

Questionnaire and subscale

Mean (s.d.)

% High scores ( n/N)

Mean (s.d.)

% High scores ( n/N)

Mean (s.d.)

% High scores ( n/N)

Mean (s.d.)

% High scores ( n/N)

POMS tension-anxiety

3.77 (3.48)

10.5 (14/133)

5.07 (4.11)

19.4 (35/180)

3.38 (3.75)

8.9 (26/292)

2.39 (2.89)

4.8 (11/229)

Depression-dejection

2.52 (4.57)

7.5 (10/133)

2.42 (3.65)

5.1 (9/178)

2.40 (4.10)

6.5 (19/292)

1.75 (3.49)

3.1 (7/228)

Anger-hostility

2.94 (3.56)

6.8 (9/132)

2.89 (3.37)

5.6 (10/179)

2.40 (3.43)

6.2 (18/292)

1.89 (2.68)

3.9 (9/229)

Fatigue-inertia

4.44 (4.30)

12.0 (16/133)

3.34 (3.37)

5.0 (9/180)

3.83 (4.19)

7.5 (22/294)

3.44 (3.53)

4.4 (10/229)

Confusion-bewilderment

2.62 (2.67)

8.3 (11/133)

2.56 (2.56)

6.7 (12/178)

2.16 (2.66)

6.9 (20/292)

1.75 (2.19)

4.8 (11/229)

IES distress (total score)

2.35 (4.43)

0.8 (1/129)

11.74 (13.76)

19.3 (33/171)

9.51 (12.32)

16.9 (49/290)

4.88 (8.82)

9.7 (22/227)

  1. Abbreviations: IES=Impact of Events Scale; POMS=Profile of Mood States; PSA=prostate-specific antigen.
  2. aThresholds for clinical scores (see text for definitions): POMS tension-anxiety 9.0, depression-dejection 9.4, anger-hostility 8.3, fatigue-inertia 10.9, confusion-bewilderment 6.6; IES distress 19.0.
  3. n/N=number of cases/number completing subscale.
  4. Data are cross-sectional at each assessment time-point, from the whole study sample.